Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 306

Similar articles for PubMed (Select 16468961)

1.

C4d in acute rejection after liver transplantation--a valuable tool in differential diagnosis to hepatitis C recurrence.

Schmeding M, Dankof A, Krenn V, Krukemeyer MG, Koch M, Spinelli A, Langrehr JM, Neumann UP, Neuhaus P.

Am J Transplant. 2006 Mar;6(3):523-30.

2.

ELISA-based detection of C4d after liver transplantation--a helpful tool for differential diagnosis between acute rejection and HCV-recurrence?

Schmeding M, Kienlein S, Röcken C, Neuhaus R, Neuhaus P, Heidenhain C, Neumann UP.

Transpl Immunol. 2010 Aug;23(4):156-60. doi: 10.1016/j.trim.2010.06.002. Epub 2010 Jun 14.

PMID:
20558292
3.

Characterization of CD4, CD8, CD56 positive lymphocytes and C4d deposits to distinguish acute cellular rejection from recurrent hepatitis C in post-liver transplant biopsies.

Jain A, Ryan C, Mohanka R, Orloff M, Abt P, Romano J, Bryan L, Batzold P, Mantry P, Bozorgzadeh A.

Clin Transplant. 2006 Sep-Oct;20(5):624-33.

PMID:
16968489
4.

C4d in acute rejection after liver transplantation and its usefulness in differential diagnosis between acute liver rejection and hepatitis C recurrence.

Gierej B, Kobryń K, Gierej P, Górnicka B.

Ann Transplant. 2014 Aug 1;19:373-81. doi: 10.12659/AOT.890234.

5.

C4d: a marker for hepatic transplant rejection.

Lorho R, Turlin B, Aqodad N, Triki N, de Lajarte-Thirouard AS, Camus C, Lakehal M, Compagnon P, Dupont-Bierre E, Meunier B, Boudjema K, Messner M.

Transplant Proc. 2006 Sep;38(7):2333-4.

PMID:
16980082
6.

An immunohistochemical evaluation of C4d deposition in pediatric inflammatory liver diseases.

Bouron-Dal Soglio D, Rougemont AL, Herzog D, Soucy G, Alvarez F, Fournet JC.

Hum Pathol. 2008 Jul;39(7):1103-10. doi: 10.1016/j.humpath.2007.12.014.

PMID:
18570976
7.

Acute humoral rejection and C4d immunostaining in ABO blood type-incompatible liver transplantation.

Haga H, Egawa H, Fujimoto Y, Ueda M, Miyagawa-Hayashino A, Sakurai T, Okuno T, Koyanagi I, Takada Y, Manabe T.

Liver Transpl. 2006 Mar;12(3):457-64.

8.

The role of C4d immunostaining in the evaluation of the causes of renal allograft dysfunction.

Ranjan P, Nada R, Jha V, Sakhuja V, Joshi K.

Nephrol Dial Transplant. 2008 May;23(5):1735-41. Epub 2007 Dec 8.

9.

The fate of C4d positive kidney allografts lacking histological signs of acute rejection.

Dickenmann M, Steiger J, Descoeudres B, Mihatsch M, Nickeleit V.

Clin Nephrol. 2006 Mar;65(3):173-9.

PMID:
16550748
10.

Significance of complement split product C4d in ABO-compatible liver allograft: diagnosing utility in acute antibody mediated rejection.

Ali S, Ormsby A, Shah V, Segovia MC, Kantz KL, Skorupski S, Eisenbrey AB, Mahan M, Huang MA.

Transpl Immunol. 2012 Jan;26(1):62-9. doi: 10.1016/j.trim.2011.08.005. Epub 2011 Sep 1.

PMID:
21907804
11.

Significance of C4d deposition in the diagnosis of rejection after liver transplantation.

Bu X, Zheng Z, Yu Y, Zeng L, Jiang Y.

Transplant Proc. 2006 Jun;38(5):1418-21.

PMID:
16797320
12.

Peritubular capillary C4d staining in late acute renal allograft rejection--is it relevant?

Satoskar AA, Lehman AM, Nadasdy GM, Sedmak DD, Pesavento TE, Henry ML, Pelletier RP, Ferguson RM, Nadasdy T.

Clin Transplant. 2008 Jan-Feb;22(1):61-7. doi: 10.1111/j.1399-0012.2007.00745.x.

PMID:
18217907
13.

Tissue hepatitis C virus RNA quantification and protein expression help identify early hepatitis C virus recurrence after liver transplantation.

D'Errico-Grigioni A, Fiorentino M, Vasuri F, Gruppioni E, Fabbrizio B, Zucchini N, Ballardini G, Morelli C, Pinna AD, Grigioni WF.

Liver Transpl. 2008 Mar;14(3):313-20. doi: 10.1002/lt.21375.

14.

Immunohistochemical evidence of activated lectin pathway in kidney allografts with peritubular capillary C4d deposition.

Imai N, Nishi S, Alchi B, Ueno M, Fukase S, Arakawa M, Saito K, Takahashi K, Gejyo F.

Nephrol Dial Transplant. 2006 Sep;21(9):2589-95. Epub 2006 Apr 27.

15.

c-Kit-positive mast cells in portal tracts cannot be used to distinguish acute cellular rejection from recurrent hepatitis C infection in liver allografts.

Doria C, di Francesco F, Marino IR, Ramirez CB, Frank A, Iaria M, Galati SA, Farber JL.

Transplant Proc. 2006 Dec;38(10):3597-600.

PMID:
17175342
16.

The use of hepatitis C viral RNA levels in liver tissue to distinguish rejection from recurrent hepatitis C.

Gottschlich MJ, Aardema KL, Burd EM, Nakhleh RE, Brown KA, Abouljoud MS, Hirst K, Moonka DK.

Liver Transpl. 2001 May;7(5):436-41.

17.

Incidence and importance of c4d deposition in renal allograft dysfunction.

Demirci C, Sen S, Sezak M, Sarsik B, Hoşcoşkun C, Töz H.

Transplant Proc. 2008 Jan-Feb;40(1):174-7. doi: 10.1016/j.transproceed.2007.11.055.

PMID:
18261578
18.

Current views on rejection pathology in liver transplantation.

Neil DA, Hübscher SG.

Transpl Int. 2010 Oct;23(10):971-83. doi: 10.1111/j.1432-2277.2010.01143.x. Review.

PMID:
20723179
19.

The value of C4d deposit in post liver transplant liver biopsies.

Fayek SA.

Transpl Immunol. 2012 Dec;27(4):166-70. doi: 10.1016/j.trim.2012.08.004. Epub 2012 Aug 27.

PMID:
22975227
20.

C4d deposition in acute rejection: an independent long-term prognostic factor.

Herzenberg AM, Gill JS, Djurdjev O, Magil AB.

J Am Soc Nephrol. 2002 Jan;13(1):234-41.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk